Search
-
Patient & Caregiver Education
Эта информация поможет вам подготовиться к выписке из больницы после терапии иммунными эффекторными клетками (Immune Effector Cell (IEC)). Читая этот раздел, записывайте возникающие у вас вопросы, чтобы затем задать их вашей лечащей команде.
… Эта информация поможет вам подготовиться к выписке из больницы после терапии иммунными эффекторными клетками (Immune Effector Cell (IEC)). Читая этот раздел, записывайте возникающие у вас вопросы, чтобы затем задать их вашей лечащей команде. Подготовка к выписке из больницы после терапии IEC После проведения
-
Patient & Caregiver Education
本信息将帮助您在接受免疫效应细胞 (IEC) 治疗后做好出院准备。 当您阅读本文时,请写下您的所有疑问,以便记得向您的医疗团队咨询。
… 本信息将帮助您在接受免疫效应细胞 (IEC) 治疗后做好出院准备。 当您阅读本文时,请写下您的所有疑问,以便记得向您的医疗团队咨询。 接受 IEC 治疗后准备出院 治疗结束后,医疗团队将确保您已做好回家准备。 如果符合以下条件,您就可以出院了: 没有发热(体温 100.4°F (38°C) 或更高)。 没有任何神经毒性(神经系统变化)的体征。 一些例子可能包括意识模糊或找词困难。 没有细胞因子释放综合征 (CRS) 的体征。 CRS 是这种治疗的常见副作用, 会引起头晕、发热和流感样症状,例如肌肉疼痛和寒战。 向社工咨询住房事宜(如有需要) 如果您的住所距离 MSK 超过 1 至 2 小时车程,
-
-
The Michael Berger Lab
… Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort. Arora K, Tran TN, Kemel Y, Mehine M, Liu YL, Nandakumar S, Smith SA, Brannon AR, Ostrovnaya I, Stopsack KH, Razavi P, Safonov A, Rizvi HA, Hellmann MD, Vijai J, Reynolds TC, Fagin JA, Carrot-Zhang
-
News
MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.
… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.
-
The David Solit Lab
… Job Title Research Fellow Degree PhD Email [email protected] Lab Phone 646-888-2649
-
The Jonathan Coleman Lab
… Kim K, Hu W, Audenet F, Almassi N … Hakimi AA, Rosenberg JE, Iyer G, Vargas HA, Scaltriti M, Al-Ahmadie H, Solit DB, Coleman JA . Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts. Nat Commun. 2020 Apr 24;11(1):1975. doi: 10.1038/s41467-020-
-
The stage of appendix cancer is determined by the size of the tumor and whether it has spread. Carcinoid tumors and carcinomas are staged differently.
… If a tumor is found, your doctor will determine its stage by judging its size and how far it has progressed. The cancer can be localized (which means it has not spread outside of the appendix), regional (spread to lymph nodes, tiny bean-shaped organs that help the body fight infections), and metastatic
-
News
Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.
… Monday, October 24, 2022 Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives. Today the U.S. Food and Drug Administration (FDA) approved a combination of the immunotherapy drugs durvalumab (Imfinzi®) plus the experimental drug tremelimumab for people with
-
Patient & Caregiver Education
Esta información de Lexicomp® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud.
… Esta información de Lexicomp ® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud. Nombres comerciales: EE. UU. PreHevbrio [DSC] ¿Para qué se utiliza este medicamento? Este medicamento